A novel additive manufacturing knee brace to improve symptoms, biomechanics and daily life in medial knee osteoarthritis: a crossover randomized controlled trial

Peacocks Medical Group Ltd (UK)0 个研究点目标入组 10 人开始时间: 2016年8月16日最近更新: 2021年6月7日

试验速览

暂无简介。

•1. Male or female aged between 40 and 70 years old having radiological and symptomatic medial knee osteoarthritis (Kellgren-Lawrence grade II, III or IV) according to the American College of Rheumatology’s clinical and radiological criteria (Altman, 1986)
•2. Average knee pain > 4/10 (VAS score assessed three times in two weeks before being included)
•3. Not currently wearing knee brace
•4. Varus knee alignment equal or superior to 2°
•5. No or light pain from the hips, ankles, feet or lumbar spine
•6. Moderately physically active
•7. Able to understand written and spoken English

•1. Mild knee osteoarthritis (Kellgren-Lawrence grade I)
•2. Lateral or patellar knee osteoarthritis
•3. Chronic diseases or conditions (e.g., diabetes, osteoporosis, heart disease, hypertension, neurological disorders)
•4. Stroke history
•5. Inflammatory arthritis (gout, rheumatoid arthritis, psoriatic arthritis etc)
•6. Musculoskeletal disorders that could influence their ability to stand and walk
•7. Morbid obesity (BMI > 35)
•8. Intra-articular corticosteroid/hyaluronan injection in the affected knee in the past 3 months
•9. Unstable medication schedule and medication that causes dizziness
•10. Severe recent modification of diet
•11. Prosthetic implants in the hip, knee or ankle joint
•12. Poor skin condition
•13. Unable to walk, walk up and down stairs or any condition contraindicating the demands of the gait analysis

发起方

Peacocks Medical Group Ltd (UK)